Independent information and tools for life in IrelandUnderstand. Decide. Compound.

COMPOUND STOCKS / COMPANY PROFILE

Agilent Technologies (A)

Stock chart, financial results, filings and related coverage. Health Care · US SEC CIK 0001090872.

Tickers: A. Official SEC filings ↗ · SEC financial facts ↗

MARKET DATA / TRADINGVIEW

Interactive stock chart

Explore the historical share price. The chart below is supplied by TradingView, not the SEC, and is separate from the financial results on this page.

A

Interactive chart loads as you scroll to it.

Market data may be delayed or unavailable for some securities. Agilent Technologies (A) chart by TradingView. TradingView branding and market-data attribution remain visible.

VERIFIED SEC RESULTS / ONE UPDATING COMPANY REPORT

Fiscal earnings through Q3

FY2026 · last reported period ended 2026-07-31

Fiscal quarters follow Agilent Technologies's official accounting calendar, not calendar-year labels. FY2026 Q3 ended 2026-07-31 and was filed 2026-09-01. This report is updated in place, not republished as a new article every quarter.

Q3 versus Q2 growth will appear only after both quarters are verified for the same fiscal year. Missing periods are never guessed or filled from annual totals.

Year-to-date totals are withheld until all preceding standalone quarters in this fiscal year have verified values. Previous-year figures may be used only for valid same-quarter comparisons.

Reported US GAAP standalone quarters for fiscal year 2026. — means not yet verified.
Fiscal quarterPeriod endedRevenue (USD)Net income (USD)Diluted EPSSEC source
FY2026 Q1 Not verified or not yet filed
FY2026 Q2 Not verified or not yet filed
FY2026 Q3 2026-07-31$1.88bn$362.00m$1.28Original Q3 filing ↗

Revenue by fiscal quarter

Q1
—
Q2
—
Q3
$1.88bn

Net income by fiscal quarter

Q1
—
Q2
—
Q3
$362.00m

Diluted EPS by fiscal quarter

Q1
—
Q2
—
Q3
$1.28

These are standalone quarterly US GAAP values sourced from original SEC filings. Net income and diluted EPS may be negative; bars show absolute magnitudes, not direction. Quarterly growth is omitted when the comparison base is zero or negative. Annual 10-K figures are not mislabelled as Q4. Financial data is not personalised investment advice.

COMPOUND RESEARCH DESK

Company news & research

0 linked articles

Company research library

Dedicated analysis and company-specific news will appear here as they're published and linked to this ticker. See current earnings reports for primary-source financial coverage.

SOURCES & LIMITATIONS

How to read this profile

Listing information and sectors follow dated public market sources and may change. Share prices come from TradingView, may be delayed and should not be confused with verified SEC accounting results.

Automated reports are checked against 10-Q and 10-K filings but are not individually reviewed before publication. Reporting standards vary. This material is for information only, not a personal recommendation. Editorial policy.

YOUR PRIVACY

Help us understand what gets read.

With your permission, anonymous Google Analytics measurements tell us which articles are useful. We do not send calculator entries or form values. You can decline and still read everything.